Similar finding were reported for BCMA-CAR T cells [21, 22] and CD19-CAR T cells [16, 19], showing that CAR T cells produced from less differentiated T cells possess greater anti-tumor activity and proliferation potential. The gene discussed is CD19; the disease is neoplasm.